PubRank

Robby Nieuwlaat

Author PubWeight™ 50.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2009 14.06
2 A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010 10.29
3 Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010 2.59
4 Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ 2013 2.58
5 Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial. Circulation 2012 1.91
6 Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 2008 1.68
7 Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace 2012 1.67
8 Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients. Eur Heart J 2011 1.60
9 Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. Europace 2010 1.59
10 Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort. Europace 2011 1.57
11 Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. Eur Heart J 2008 1.57
12 Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls. Heart Rhythm 2012 1.53
13 Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007 1.42
14 The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med 2013 1.20
15 Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges. Eur Heart J 2013 1.01
16 Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol 2005 1.00
17 Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. J Clin Invest 2003 0.95
18 Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Qual Life Res 2010 0.95
19 Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms. Semin Thromb Hemost 2009 0.83
20 Comprehensive upstream treatment for atrial fibrillation, when and how? Europace 2009 0.83
21 Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey. Thromb Haemost 2012 0.83
22 Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation. Aging Clin Exp Res 2012 0.82
23 Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes. Heart 2008 0.79
24 The value of cardiovascular hospitalization as an endpoint for clinical atrial fibrillation research. Europace 2011 0.76
25 The Euro Heart Survey program: what's in it for nurses? Prog Cardiovasc Nurs 2007 0.75